Altimmune
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Altimmune's past years’ income statements indicate that its last revenue has increased compared to the previous period by 726% to $426,000. Profit margin reached -20762%. Total operating expenses were $96,355,000.

Profit Margin

Altimmune, Inc. (NASDAQ:ALT): Profit margin
2014 10.19M -9.95M -97.7%
2015 10.64M -3.44M -32.34%
2016 5.23M 193.85M 3706.44%
2017 41.50K -46.42M -111860.32%
2018 10.33M -39.17M -379.16%
2019 5.80M -20.52M -353.71%
2020 8.18M -49.04M -599.2%
2021 4.41M -96.17M -2180.58%
2022 -68K -84.71M 124577.94%
2023 426K -88.44M -20762.21%

ALT Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
426K-68K4.41M8.18M5.80M10.33M41.50K5.23M10.64M10.19M
Cost of revenue
477K68K551.30K33.50M17.06M018.40M05.06M4.26M
Gross profit
-51K-136K3.85M-25.32M-11.26M10.33M-18.36M5.23M5.57M5.92M
Operating exp.
Research and development
65.79M70.53M74.54M49.77M17.76M18.45M18.40M4.83M5.13M9.31M
Selling and marketing
0000000000
Total operating expenses
96.35M87.67M89.95M62.98M26.26M28.22M16.16M16.49M11.49M20.38M
Operating income
-95.92M-87.74M-96.91M-54.79M-21.46M-42.83M-52.04M-11.26M-3.40M-10.19M
Other income (expenses), net
7.48M2.83M-176.78K337.24K886.30K-27.35M-18.50K216.11M3.20M297.65K
Income before tax
-88.44M-84.91M-97.09M-54.46M-20.57M-45.32M-52.06M205.02M-3.37M-9.89M
Income tax expense
0-197K-919.51K-5.41M-58.5K-6.14M-5.63M11.16M61.74K61.74K
Net income
-88.44M-84.71M-96.17M-49.04M-20.52M-39.17M-46.42M193.85M-3.44M-9.95M
Earnings per share
Basic EPS
-1.66-1.81-2.33-1.91-1.56-13.98-108.77-49.8-16.13-51.91
Diluted EPS
-1.66-1.81-2.33-1.91-1.56-13.98-108.77-49.8-16.13-51.91
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source